Connection

Erin Weeda to Aged

Back to Details
This is a "connection" page, showing publications Erin Weeda has written about Aged.
Erin Weeda
Connection Strength
1.094
Aged
  1. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449.
    View in: PubMed
    Score: 0.059
  2. Influence of hospital encounters for falls on potentially inappropriate medication use among older patients. Geriatr Gerontol Int. 2020 Aug; 20(8):795-796.
    View in: PubMed
    Score: 0.058
  3. Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499.
    View in: PubMed
    Score: 0.057
  4. Loop diuretic use among patients with heart failure and type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors. J Diabetes Complications. 2019 08; 33(8):567-571.
    View in: PubMed
    Score: 0.054
  5. Saddle pulmonary embolism and in-hospital mortality in patients with cancer. Int J Clin Oncol. 2019 Jun; 24(6):727-730.
    View in: PubMed
    Score: 0.053
  6. Comorbid cancer and use of thrombolysis in acute pulmonary embolism. J Thromb Thrombolysis. 2019 Feb; 47(2):324-327.
    View in: PubMed
    Score: 0.053
  7. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Support Care Cancer. 2019 Mar; 27(3):921-925.
    View in: PubMed
    Score: 0.051
  8. Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis. Int J Stroke. 2019 01; 14(1):48-52.
    View in: PubMed
    Score: 0.050
  9. External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer. J Natl Compr Canc Netw. 2017 12; 15(12):1476-1482.
    View in: PubMed
    Score: 0.048
  10. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 02; 32(2):210-215.
    View in: PubMed
    Score: 0.048
  11. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Int J Clin Pract. 2017 Jan; 71(1).
    View in: PubMed
    Score: 0.046
  12. Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism. J Thromb Thrombolysis. 2016 Nov; 42(4):513-9.
    View in: PubMed
    Score: 0.045
  13. Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318.
    View in: PubMed
    Score: 0.045
  14. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115.
    View in: PubMed
    Score: 0.045
  15. Association between weekend admission and mortality for upper gastrointestinal hemorrhage: an observational study and meta-analysis. Intern Emerg Med. 2017 Mar; 12(2):163-169.
    View in: PubMed
    Score: 0.044
  16. Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban. Int J Cardiol. 2016 Nov 01; 222:846-849.
    View in: PubMed
    Score: 0.044
  17. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clin Appl Thromb Hemost. 2017 Oct; 23(7):769-774.
    View in: PubMed
    Score: 0.044
  18. Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs. Int J Cardiol. 2016 Jan 01; 202:427-9.
    View in: PubMed
    Score: 0.042
  19. The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues. 2022 May-Jun; 32(3):274-283.
    View in: PubMed
    Score: 0.016
  20. Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy. JAMA Surg. 2021 07 01; 156(7):639-645.
    View in: PubMed
    Score: 0.016
  21. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
    View in: PubMed
    Score: 0.015
  22. Association Between Potentially Inappropriate Medications and Hospital Encounters Among Older Adults: A Meta-Analysis. Drugs Aging. 2020 07; 37(7):529-537.
    View in: PubMed
    Score: 0.015
  23. Weight-based versus non-weight-based diltiazem dosing in the setting of atrial fibrillation with rapid ventricular response. Am J Emerg Med. 2020 11; 38(11):2271-2276.
    View in: PubMed
    Score: 0.014
  24. Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. J Oncol Pharm Pract. 2020 Jun; 26(4):861-865.
    View in: PubMed
    Score: 0.014
  25. Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria. Diabet Med. 2020 01; 37(1):44-52.
    View in: PubMed
    Score: 0.014
  26. Assessment of intravenous insulin dosing strategies for the treatment of acute hyperkalemia in the emergency department. Am J Emerg Med. 2020 06; 38(6):1082-1085.
    View in: PubMed
    Score: 0.014
  27. Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin. Neurocrit Care. 2019 04; 30(2):301-306.
    View in: PubMed
    Score: 0.013
  28. Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients. Clin Cardiol. 2018 Jan; 41(1):119-125.
    View in: PubMed
    Score: 0.012
  29. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. J Thromb Haemost. 2018 02; 16(2):279-292.
    View in: PubMed
    Score: 0.012
  30. Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis. BMC Pulm Med. 2017 Feb 13; 17(1):37.
    View in: PubMed
    Score: 0.011
  31. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. 2017 Aug; 12(5):613-619.
    View in: PubMed
    Score: 0.011
  32. External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610.
    View in: PubMed
    Score: 0.011
  33. Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837.
    View in: PubMed
    Score: 0.011
  34. Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination. Thromb Res. 2016 May; 141:8-10.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.